Your browser doesn't support javascript.
loading
Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.
DuPont, Herbert L; Almenoff, June S; Jamindar, Mansi S; Bortey, Enoch; Steffen, Robert.
Affiliation
  • DuPont HL; Internal Medicine, University of Texas School of Public Health, Houston, TX 77030, USA.
  • Almenoff JS; Department of Medical Affairs, Redhill Biopharma Inc., Raleigh, NC 27617, USA.
  • Jamindar MS; Department of Medical Affairs, Redhill Biopharma Inc., Raleigh, NC 27617, USA.
  • Bortey E; Pharmaceutical Development Strategies LLC, Chapel Hill, NC 27517, USA.
  • Steffen R; Department of Epidemiology, University of Zurich, 8001 Zurich, Switzerland.
J Travel Med ; 30(6)2023 10 31.
Article in En | MEDLINE | ID: mdl-37052453
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifamycins / Travel Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Travel Med Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifamycins / Travel Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Travel Med Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido